AEON BIOPHARMA

AEON Biopharma is the only company dedicated exclusively to the use of botulinum toxins for therapeutic-only indications. With ABP-450 (prabotulinumtoxinA), we are advancing a well-established product into fast growing markets for both expanded and novel indications utilizing a differentiated business model intended to deliver enhanced pharmacoeconomics to payers and providers... AEON is developing ABP-450, a proprietary botulinum toxin, to unlock the promise of therapeutic botulinum toxin to treat nervous system-related conditions... We operate at the forefront of neurotoxin research, development, and commercialization, and we have just begun to scratch the surface of what's possible. Our lead candidate, ABP-450 (prabotulinumtoxinA), has the potential to improve the lives of patients living with a range of nerve and muscle-based disorders.

Also known as: AEON Biopharma, Inc.

Primary location: Irvine United States